Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

  • 00:31

    Pharma to Dharma: From Pharmaceuticals Back to Nature

    in Health

    Today Nick & Dr. Joanna will be talking about her initiative called, "Pharma to Dharma: From Pharmaceuticals Back to Nature." The Wetsern model of quick fix medicine is just not working, for doctors and patients alike.  Patients are finally realizing that the "quick fix" really isn't giving them the desired result or cure that they are looking for, and doctors are starting to feel that this is not the way to truly practice medicine so that healing on all levels can be invited to occur.  


    Adverse Drug reactions are the 4th leading cause of death and pharmaceutical companies still continue to rake in billions by marketing and selling disease.  How do they do that?  By creating new diagnoses that fit into the effects of the drug that is already on the market, but that is usually close to patent expiration. This occurs particularly with psychotropics - drugs for anxiety, insomnia, depression and a variety of other psychiatric illnesses. Many people do not realize that sometimes the side effects of these drugs are exactly that which they are designed to treat.  


    How does the food industry fit in to all of this?  And it's supposedly monitored by the FDA.  But there's a reason it's called the F D A. 


    So what can we do as healthcare practitioners and consumers of medical care to combat the collusion amongst big pharma, medicine, the mainstream media, and the food industry to keep us fat, sick and dying? Find out in what promises to be a very interesting discussion.


    Pharma to Dharma 4-hour Workshops on 17th & 21st May 2015 and will be offered regularly. See more on the Kalyana Centre homepage.


    Find us always at www.thekalyanacentre.com or Dr. Joanna at www.drjoannacarmichael.com or 484-412-8815.


    Receive 20% off an initial consultation with Nick or Joanna when you mention this show. 


     

  • 00:33

    Big Data & Big Pharma: How Analytics Might Save Your Life

    in Technology

    Long before the tech sector christened almost every type of analytics as big data, the pharmaceutical and biotech industries were heavily reliant on analytics to develop new, safer drugs, and to produce those drugs more efficiently. Big data plays a key role in building upon what we have learned about the human genome, in managing effective clinical trials, in long-term monitoring of drug applicability in real-world healthcare, and in managing the manufacturing process.


    Consider what the use of big data in pharma and biotech companies means to you as a consumer. It means getting the right drug to the right patient at the right time for the right condition. Now, consider what you can learn as a business person -- no matter what industry you are in -- from the analytics techniques, and the data management and data mining concepts pioneered by big pharma.


    Jim Baxter, head of the life sciences practice at Collaborative Consulting, joins All Analytics Radio on Tuesday, May 19, at 2 pm EDT, for a discussion of how pharma and biotech companies finding benefits in big data analytics.


    In this show you will learn:



    How use of big data analytics have evolved in the drug and medical device industries
    What types of benefits life sciences companies are finding through use of analytics
    What big data in pharma means to you as a possible patient
    What the future holds for use of analytics in life sciences
    What lessons big pharma can teach analytics professionals and decision makers about use of big data in their own business environments

  • 00:30

    Mobile Technology, Pharma & the Future of Healthcare

    in Business

    The Mobile Health Competence Centre Hosts Online Discussions


    Pharmaguy interviews Juan Cornet, Director, mHealth Competence Center, who summarizes the key takeaways from an hour-long #mHealthPharma TweetChat on how pharma can develop high quality mobile health apps. Juan also talks more generally about the impact of mobile technology on healthcare and what his organization is doing to promote quality mHealth programs.


    Questions/Topics of Discussion



    Tell us about the mHealth Competence Center and its mission.
    What did you learn from the LinkedIn debate and #mHealthPharma TweetChat? Do you plan more such discussions?
    What other activities is he mHealth Competence Center involved in now or planned for the future?
    What's your view on how mHealth can improve health inequalities that exist today? What role do you see for pharmaceutical companies?

  • 00:22

    Pharma Brand Ads Within Mobile Apps

    in Business

    Myrbetriq®'s Advertising Partnership with RunPee App


    Pharmaguy interviews Walt Johnston, Vice President of US Marketing and New Product Planning, and Emily Sitrin Mason, Consumer Marketing Director - Urology Franchise, at Astellas (see Bios). We discuss a new partnership with Astellas Pharma US and the RunPee mobile app as part of the company's marketing campaign for Myrbetriq® (mirabegron) featuring an animated bladder character. 


    The RunPee app is a movie-viewing app that tells you the best time to "run and pee" without missing the best scenes. While the ultimate goal is to encourage individuals to speak with a health care professional about overactive bladder (OAB), Astellas is encouraging those who experience symptoms of OAB to enjoy the movies this summer and download the app to determine the best time to use the restroom during movies if needed. 


    Questions/Topics of Discussion



    Give us a little background about this partnership. Why did Astellas decide to partner with RunPee?
    Describe how the app works
    Are branded Myrbetriq® ads served up within the app? Describe how that is done.
    What is the target audience for Myrbetriq® and how does the app help you reach this audience?
    What are are the KPIs for this campaign? Has it been successful so far? What data can you share with us?
    What have you learned from this partnership?

  • 00:13

    Schools to Start Depression Screenings = Big $$$ for Big Pharma!

    in Politics

    The largest school district in Minnesota is considering screening students for depression and anxiety.  


    This most certainly means that countless more children and teens will be the subject of a parent teacher conference where the district's psychiatrist urges the prescription of an ADHD (or ADD) medication to improve concentration, focus or happiness of the student in question.


    While the screenings are supposedly aimed at preventing more student suicides, the establishment fails to inform parents that many child and teen suicides are most likely the result of the same anti-anxiety and anti-depression medications that will be pushed following the new screenings.


    WND reported that the screenings are the result of Obama's executive action on gun control following Sandy Hook.  Many opponents argue that the goal is to document "mental illness" with  as many students as possible, so to later be used as a flag to prevent gun ownership.  Many call it a back door attack on the second amendment.


    Even if you aren't concerned with the second amendment, you should be concerned about these drugs being forced upon children and teens across America.


    Subscribe to Linc Austin here:  www.youtube.com/user/jps122979

  • 01:14

    SOCIAL MEDIA AND BIG PHARMA

    in Health

    Join us for a fierce conversation with health economist Jane Sarasohn-Kahn (Blogger at HealthPopuli and HealthcareDIY) about social media and the role of Big Pharma. For starters, is there a role for them? Tune in to find out. Survivor spotlight on Greg Grappone.
     

  • 00:26

    Mobile Strategies for Pharma

    in Business

    Pharma Must Dispel the One-Size-Fits-All Approach


    Ryan McGuire, Research Team Leader, and Sarah Ray, Research Analyst, Cutting Edge Information, join Pharmaguy to discuss top-level results of the "Pharmaceutical Mobile Health: Transforming Brand Marketing, Healthcare Communication and Patient Adherence" survey. Listen and learn how pharmaceutical companies are optimizing mobile health channels to better meet audience needs and to improve medication adherence, drug safety reporting, etc.




  • 01:05

    Bringing Down Big Pharma

    in Education

    Jeff Hays is a serial entrepreneur and filmmaker with a long colorful history of visionary projects. Following his passion for sharing truth, and exposing the controversy that all too often surrounds it, Jeff produced "Doctored" in 2012. Doctored, reveals the unseen tactics of the medical establishment and exposes deception and criminality at the highest levels of the American Medical Association (AMA) and finally shares the stories of victims left in it's wake. Jeff is currently producing a follow up film "Bought", taking a deep dive into the business of Big Pharma, the controversies with vaccines and the truth about GMOs in America's food supply. The film has already developed the support of some of the world's most acclaimed experts in research, medicine,  and natural health. Based upon the film's trailer, it has been dubbed controversial by media outlets even though it focuses on educating the public and arming people globally with the truth and facts about Big Pharma, vaccines and the food supply. Jeff believes that each person has a right to the truth and be empowered by the facts in order to make educated decisions about their own health, food and medicine.
    Links discussed in the show:
    supportboughtmovie.com
    boughtmovie.com - trailer and email list
    jeffhaysfilms.com Jeff's other productions
     

  • #PotStockRadio- with President of Supreme Pharma $SPRWF John Fowler

    in Finance

    This week on #PotStockRadio Eric @EbizDizzle Ry @ryanmgodfrey and Trace @supergravy welcome John Fowler President of Supreme Pharmaceuticals to discuss the current status and future outlook of $SPRWF. As always any questions for our guest can go to eric@potstockradio.com or use #potstockradio on Twitter! Also, don't forget to check out PotStockRadio.com for updates and future shows!


     


    PotStockRadio does not condone or promote the use of any illegal substance. Also, PotStockRadio is for informational purposes only! Nothing said on this program is solicitation to buy or sell any security or encite the use of any illegal substances.


     


    PLEASE- if you enjoy this show share it with friends and fellow PotStockers!


     

  • 00:30

    Back to the Pharma Digital Future

    in Business

    A Pharma Social Media Pioneer Looks Back & Ahead
    A conversation with Alex Butler, Managing Director at The Earthworks and recipient of the first Pharmaguy Social Media Pioneer Award. We look back over the past three years since Alex won his award at the digital pharma landscape to review what has changed, what remains the same, and what may lie ahead.

  • 00:31

    Create Squeaky-Clean Pharma Ads

    in Business

    Tricks & Tips to Avoid FDA Letters


    Pharmaguy interviews Dale Cooke, Principal, PhillyCooke Consulting, who gives us a preview of the topics he will cover during a two-day interactive workshop -- "Building a World-Class Advertising and Promotion Review Program" -- in Philadelphia on October 15 and 16, 2014. He also will share a few tips on how to comply with recent FDA social media draft guidances.


    Face it: You need help. Make sure your promotional activities aren't magnets for FDA warning letters! 

    Questions/Topics of Discussion



    Can you provide a quick review of recent FDA social media draft guidelines?
    Some experts have said that these guidances raise many more questions than they answer. Can you give us a few examples?
    Will your workshop cover these guidelines in detail? What other topics will you cover in the workshop?